HD
HDFC Focused Fund Direct Growth
Latest NAV
+4.29% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty 500 TRI
Expense ratio
0.82%
AUM
₹26,956 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
+4.29%
3Y (ann.)
+17.57%
5Y (ann.)
+17.27%
Launched
Jan 2013
Where the NAV sits & how risky it is
₹285.66
52-week range
at 100%
₹285.66
Low 30 Mar 2026₹238.13
High 12 Nov 2026₹282.23
Risk level
Very High
Low
Very high
NAV history
02 Jan 2013
Since inception
19 Nov 2026
Returns by period
1W
+3.18%
1M
+10.39%
3M
+4.18%
6M
+13.10%
1Y
+4.29%
3Y
+17.57%
5Y
+17.27%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 90.62%
Cash & other 9.78%
Sector split
Country split
Top 5 hold 35.3%
Top 10 hold 53.9%
29 equity holdings
Equity holdings
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
9.01%
|
-0.64% |
| 2 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
8.14%
|
-20.81% |
| 3 | Axis Bank
INE238A01034 |
Financial Services Banks - Regional |
India |
7.40%
|
+7.79% |
| 4 | Kotak Bank
INE237A01036 |
Financial Services Banks - Regional |
India |
5.56%
|
-7.35% |
| 5 | State Bank of India
INE062A01020 |
Financial Services Banks - Regional |
India |
5.22%
|
+5.14% |
| 6 | HCL Technologies
INE860A01027 |
Technology Information Technology Services |
India |
3.86%
|
-26.38% |
| 7 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.75%
|
-8.28% |
| 8 | Maruti Suzuki
INE585B01010 |
Consumer Cyclical Auto Manufacturers |
India |
3.70%
|
-18.00% |
| 9 | Eternal
INE758T01015 |
Consumer Cyclical Internet Retail |
India |
3.67%
|
-8.79% |
| 10 | SBI Life Insurance
INE123W01016 |
Financial Services Insurance - Life |
India |
3.62%
|
-13.40% |
About this scheme
To generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies.
Fund manager(s): Gopal Agrawal, Amit Ganatra, Bhagyesh Kagalkar
Exit load: Exit load of 1% if redeemed within 1 year
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Jan 2013
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 55.4 pts ahead of this fund
Kotak Healthcare Fund Direct Growth
2▲ 29.1 pts ahead of this fund
HDFC Pharma And Healthcare Fund Direct Growth
3▲ 27.7 pts ahead of this fund
Mirae Asset Healthcare Fund Direct Growth
4▲ 23.5 pts ahead of this fund
PGIM India Healthcare Fund Direct Growth
5▲ 22.5 pts ahead of this fund
Edelweiss Recently Listed IPO Fund Direct Growth
6▲ 22.5 pts ahead of this fund